Breschi, G. L., Demma, F., Morelli, P. and De Francesco, M. (2021) “Brentuximab vedotin in adult patients with HL CD30+ at high risk of relapse or progression following ASCT: a cost-analysis in Italy”, AboutOpen, 8(1), pp. 81–87. doi: 10.33393/ao.2021.2263.